COVID-19 vaccine in children under 12 by the end of the year, the company told Global News.In a statement, Pfizer said that it had completed its Phase 1 trial of the vaccine in children, which was designed to determine the optimal dose for kids of different age groups.Phase 2 and 3 trials are ongoing, the company said, “to further evaluate the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in children 5-11, and in children 6 months-5 years.” Provinces divided on making use of COVID-19 vaccine passports.
Here’s why “If safety and immunogenicity is confirmed, we plan on filing the data to Health Canada before the end of the year to support a potential authorization in children 5 to 11 years of age, and soon.